Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fomivirsen

Next Previous
X
Search
Drug Profile

Fomivirsen

Alternative Names: Fomivirsen sodium; ISIS 2922; Vitravene

Latest Information Update: 15 Apr 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Isis Pharmaceuticals
  • Developer Isis Pharmaceuticals; Pacira Pharmaceuticals
  • Class Antisense oligonucleotides; Antivirals; Thionucleotides
  • Mechanism of Action RNA-binding protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cytomegalovirus infections
  • New Molecular Entity Yes

Highest Development Phases

  • Market Withdrawal Cytomegalovirus infections

Most Recent Events

  • 09 Apr 2019 Pacira Pharmaceuticals is now called Pacira BioSciences
  • 11 Jan 2016 Ionis Pharmaceuticals completes a phase I/II trial in Cytomegalovirus infections in USA (Ophthalmic) before June 2005 (NCT00002187)
  • 18 Nov 2005 Fomivirsen has received Orphan Drug Status for CMV-induced retinitis in AIDS patients in Australia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top